Is the GLP-1 response to an oral glucose load increased in South Asians as compared to Western-Europeans?
- Conditions
- gut peptide GLP-1sugar disease10018424
- Registration Number
- NL-OMON40806
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 20
- 10 Male healthy volunteers of South Asian descent and 10 male healthy volunteers of western- european descent, born in the Netherlands
- Age > 18 years and * 25 years
- BMI > 20 kg/m2 and < 25 kg/m2
- A first degree (parent or sibling) relative with T2D
- Diabetes mellitus as defined by ADA criteria{2014 12 /id}
- Any significant chronic disease
- Renal, hepatic or endocrine disease
- Clinical cardiovascular disease, including complaints of angina pectoris or intermittend claudicatio
- Smoking
- Use of medication known to influence glucose and/or lipid metabolism
- Recent weight changes or attempts to loose weight (> 3 kg weight gain or loss, within the last 3 months)
- Difficulties to insert an intravenous catheter
- Recent blood donation (within the last 3 months)
- Recent participation in other research projects (within the last 3 months), participation in 2 or more projects in one year
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>- AUC GLP-1 in SA versus WE<br /><br>- peak GLP-1 level in SA versus WE<br /><br>- time to peak GLP-1 in SA versus WE<br /><br>- iinsulin sensitivity by Matsuda-index in SA versus WE</p><br>
- Secondary Outcome Measures
Name Time Method <p>- does peak GLP-1 in plasma precede the peak of plasma insulin?<br /><br>- insulin sensitivity by Matsuda-index in SA versus WE<br /><br>- is metabolic flexibility in SA impaired (switch from glucose to lipid<br /><br>metabolism and vice versa)</p><br>